Abstract
Molecular and Phenotypic Profiling of Drug Product and Post-Infusion Samples from CRB-402, an Ongoing: Phase I Clinical Study of bb21217 a BCMA-Directed CAR T Cell Therapy
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have